DAVID ONDER: Open Payments
NPI 1952036923 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,875 in 175 payments from 15 companies in 2025. Trend: 2023 $2,009 · 2024 $2,416 · 2025 $22,875
Speaker / faculty: $10,350Consulting: $6,898Food & beverage: $3,674Travel & lodging: $1,939Education: $15
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 76 | $20,795 |
| Vanda Pharmaceuticals Inc. | 17 | $457 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $369 |
| Otsuka America Pharmaceutical, Inc. | 9 | $286 |
| ABBVIE INC. | 26 | $271 |
| Supernus Pharmaceuticals, Inc. | 5 | $197 |
| Teva Pharmaceuticals USA, Inc. | 6 | $103 |
| Neurocrine BioSciences, Inc. | 5 | $88 |
| E.R. Squibb & Sons, L.L.C. | 1 | $82 |
| Axsome Therapeutics, Inc. | 4 | $73 |
Products named: LYBALVI, ARISTADA, CAPLYTA, REXULTI, VRAYLAR, HETLIOZ, Qelbree, FANAPT.
Industry payments across OH — which companies pay providers there.
